CLINICAL_TRIALS
trial_result
· 2013-05-21
Clinical Trial Update: Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia [Phase 2]
Summary
A Phase 2 trial evaluating EGb761 for Friedreich Ataxia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED | Results posted: 2013-05-21